Cargando…
Decreased placental and muscular expression of the fibroblast growth factor 19 in gestational diabetes mellitus
AIMS/INTRODUCTION: Fibroblast growth factor (FGF)19 has been shown to improve glycemic homeostasis and lipid metabolism in animal models. In humans, decreased FGF19 level has been described in diabetes. The present study aimed to investigate the expression of FGF19 in gestational diabetes mellitus (...
Autores principales: | Wang, Dongyu, Xu, Shuqia, Ding, Wenjing, Zhu, Caixia, Deng, Songqing, Qiu, Xiwen, Wang, Zilian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319613/ https://www.ncbi.nlm.nih.gov/pubmed/29734515 http://dx.doi.org/10.1111/jdi.12859 |
Ejemplares similares
-
The relationship between total cholesterol and postpartum impaired glucose tolerance in women with gestational diabetes mellitus
por: Wang, Dongyu, et al.
Publicado: (2020) -
Serum Concentrations of Fibroblast Growth Factors 19 and 21 in Women with Gestational Diabetes Mellitus: Association with Insulin Resistance, Adiponectin, and Polycystic Ovary Syndrome History
por: Wang, Dongyu, et al.
Publicado: (2013) -
Association between neonatal birthweight and risk of maternal glucose intolerance after gestational diabetes mellitus
por: Li, Zhuyu, et al.
Publicado: (2020) -
Longitudinal trends in lipid profiles during pregnancy: Association with gestational diabetes mellitus and longitudinal trends in insulin indices
por: Shen, Lixia, et al.
Publicado: (2023) -
Higher Peripheral Cholesterol and a Positive Correlation With Risk for Large-For-Gestational-Age Neonates in Pre-Pregnancy Underweight Women
por: Wang, Dongyu, et al.
Publicado: (2021)